Background. Intraoperative parathyroid hormone (IOPTH) monitoring is crucial in the treatment of primary hyperparathyroidism (PHPT). Often, the 5 min IOPTH levels fall, but not by the requisite 50 %. In such cases, the surgeon must decide whether to wait for additional levels or to continue exploration. This study aimed to evaluate the 5 min drop in IOPTH for distinguishing single adenomas (SA) from multigland disease. Methods. A retrospective analysis of a prospectively collected database was performed on PHPT patients who underwent initial curative parathyroidectomy between 2001 and 2013. Those with familial disease and those taking lithium or undergoing concomitant thyroidectomy were excluded from the analysis. For cases of double adenomas (DA) or hyperplasia (HA), the IOPTH values indicating additional glands were analyzed. Results. The inclusion criteria were met by 1021 patients: 817 patients with SA (82.2 %), 99 patients with DA (10 %), and 78 with HA (7.9 %). The SA patients exhibited a 56.6 ± 4.9 % decline in IOPTH at 5 min compared with 21.3 ± 4.5 % of the DA patients and 22.5 ± 4.3 % of the HA patients (p \ 0.01). Post hoc comparisons showed that the 5 min decrease in the SA group was significantly greater than in either the DA group or the HA group (p \ 0.01). A 5 min percentage decline of 35 % best distinguished SA from multiglandular disease (85.3 vs. 24.9 %). Conclusion. The data suggest that when IOPTH level does not drop by at least 35 % at 5 min after excision, the surgeon should consider further exploration rather than wait for additional levels.
Parathyroidectomy is the only long-term curative therapy for primary hyperparathyroidism (PHPT), 1 with a success rate of at least 95 % if performed by an experienced surgeon. 2 Because single adenoma is the cause for PHPT in up to 85 % of cases, surgeons can target a single gland for excision with a focused or minimally invasive surgery. 1, 2 Minimally invasive parathyroidectomy (MIP) relies on a careful preoperative radiologic workup to identify the location of the solitary parathyroid adenoma and on intraoperative parathyroid hormone (IOPTH) monitoring. [1] [2] [3] A decrease in IOPTH level by at least 50 % from baseline generally is considered to indicate successful surgery, 4 although much debate surrounds the exact IOPTH algorithm used. 5 This test often takes up to 30 min, which prolongs the operating time, especially for patients whose level does not fall. Many experienced surgeons become impatient because they could perform a bilateral exploration during the time it took to get the parathyroid hormone (PTH) levels reported back, and it has been suggested that further operative exploration is more time efficient. 6 If the 5 min IOPTH levels do not drop by 50 %, the surgeon must either wait for more levels or continue exploration. In this study we hypothesized that the 5 min IOPTH level alone can predict the presence of multiglandular disease. The study aimed to evaluate the early (5 min) drop in IOPTH for distinguishing single adenomas from double adenomas and hyperplasia.
METHODS
University of Wisconsin Institutional Review Board approval was obtained for a prospectively collected database of consecutive parathyroidectomies. A retrospective analysis of the database was performed for patients with PHPT who underwent initial parathyroidectomy at the University of Wisconsin Hospital between 2001 and 2013. Those with familial disease, patients with secondary/tertiary disease, those taking lithium, patients who had previous parathyroidectomy surgery, and those undergoing concomitant thyroidectomy were excluded from the analysis. Patients with at least 6 months of followup evaluation were included and divided into three groups according to the surgeon's final diagnosis as follows: single adenoma (SA), double adenoma (DA), or hyperplasia (HA). In all cases of DA or HA, the initial IOPTH values indicating additional glands were analyzed.
A postoperative serum calcium level higher then 10.2 mg/dl within 6 months after surgery was defined as a persistent disease, whereas an elevated calcium level after 6 months was defined as a recurrence. The baseline reading was defined as the pre-incision PTH level except for those patients who exhibited a 5 min level above the pre-incision level due to manipulation of the gland.. In this case, the 5 min PTH reading was considered to be the baseline reading, as we have reported previously. 7 Thus, either the pre-incision level or the 5 min level was used as the baseline for all further calculations of slope or percentage decline in PTH.
Two comparisons have been included. The first compared cured SA, DA, and HA, and the second compared patients with cured SA and SA patients with persistence, recurrence, or both. Patient data, preoperative calcium and PTH levels, and the mean and percentage of IOPTH decline were compared between these groups. Comparisons between the groups were made using analysis of variance (ANOVA), the Chi square test, Fisher's exact test, Student's t test, and the Wilcoxon rank-sum test where appropriate. Selected post-estimation comparisons were performed using the Bonferroni adjustment. Finally, sensitivity analysis was carried out to determine a threshold decline in IOPTH that identified multigland disease.
All statistical calculations were performed using statistical software SAS version 9.2 (SAS Institute Inc., Cary, NC, USA). A p value of 0.05 or lower was considered to represent statistical significance for all comparisons.
RESULTS
The inclusion criteria was met by 1021patients, and the success rate for parathyroidectomy was 97.3 %. The median age of the patients was 61 years (range 18-91 years), and 79 % were female. The median preoperative calcium level was 10.9 mg/dl (range 8.06-16.2 mg/ dl), and the median preoperative PTH level was 98 pg/ml (range 35-2000 pg/ml). The overall number of PHPT treatment failures (persistence and recurrence) was 3.2 %. The median follow-up period was 14 months (range 6-127 months).
The findings showed 817 patients (82 %) with SA, 99 patients (10 %) with DA, and 78 patients (8 %) with HA. The groups did not differ in terms of age, gender, or creatinine. However, the SA group had higher preoperative calcium and PTH levels (respectively 11.0 ± 0.88 and 123.3 ± 10.0 pg/ ml) than the DA group (respectively 10.7 ± 0.91 and 105.5 ± 8.0 pg/ml) or the HA group (respectively 10.7 ± 0.84 and 99.1 ± 7.5 pg/ml) (p \ 0.01; Table 1 ).
The rates of decline in IOPTH 5 min after excision were 22.17 ± 1.09 pg/ml/min in the SA group, 5.08 ± 1.32 pg/ ml/min in the DA group, and 5.85 ± 1.33 pg/ml/min in the HA group (p \ 0.01). The SA group exhibited a 56.6 ± 4.9 % decline in IOPTH at 5 min compared with 21.3 ± 4.5 % in the DA group and 22.5 ± 4.3 % in the HA group (p \ 0.01). Post hoc comparisons showed that the 5 min decrease in the SA group was significantly greater than in either the DA or the HA group (p \ 0.01), but the DA and HA groups did not differ (p = 0.90; Table 1 ; Fig. 1 ).
Sensitivity analysis showed that a 5 min percentage decline of 35 % best distinguished SA from DA and HA with a sensitivity of 84 %, a specificity of 79 %, a positive predictive value of 95 %, and a negative predictive value of 52 %. In the SA group, 85.3 % achieved a 35 % decline in IOPTH at 5 min, whereas only 24.9 % of those with multigland disease met this threshold (p \ 0.01; Fig. 2 ). In our cohort, 120 patients (12 %) who would have gone onto bilateral exploration using the rule of 35 % at 5 min ultimately had only an SA.
SA Subset Analysis
In the SA group, recurrence or persistence was identified in 27 patients (2.7 %). We compared those cured with those who experienced recurrence or persistence in the SA group and found no differences in terms of age, gender, or preoperative calcium. However, SA (cured) had a higher preoperative PTH level (123.3 ± 10.0 vs. 115 ± 11.0 pg/ ml) for the SA (recurrence or persistence) (p \ 0.01). Moreover, a comparison of the percentage decrease in IOPTH at 5 min showed that the cured group dropped by 56.6 %, whereas those with recurrence or persistence dropped by 43 % (p = 0.01; Table 2 ).
DISCUSSION
Our data suggest that the percentage of decline in IOPTH 5 min after excision was higher in the cured SA group than in the group with multigland disease but that the DA and HA groups showed no difference. Moreover, the percentage decline in IOPTH 5 min after excision was higher in the cured SA group than in the recurrence and persistence SA group. Finally, a 5 min percentage decline of 35 % best distinguished SA from multigland disease.
Therefore, the use of early IOPTH levels can identify multigland disease. This report aims to provide guidance when the initial 5 min level drops from the baseline but does not meet the 50 % threshold. Should the surgeon wait for the next level or simply undertake further exploration? When the IOPTH level does not drop by at least 35 % at 5 min after excision, the surgeon should consider further exploration rather than wait for additional levels. This information enables the surgeon to use operative time in the most efficient manner.
The literature clearly demonstrates the important role of a baseline PTH level drop of at least 50 % within 10-20 min after excision of an abnormal gland in predicting a curative result. [8] [9] [10] [11] If the IOPTH level fails to drop by at least 50 %, the surgeon must consider multiglandular disease and undertake additional exploration. 12 However, some controversy exists concerning the role of the IOPTH level in multiglandular disease, specifically in DA cases. 13, 14 Supporting one view, Stratmann et al. 15 demonstrated the reliability and accuracy of the IOPTH assay in multiglandular parathyroid disease. 16, 17 Similarly, data from our group showed that the IOPTH assay is sensitive for multigland disease detection, allowing surgeons to recognize and resect additional hyperfunctioning parathyroids intraoperatively, which improved cure rates for patients undergoing MIP. 10, 18 In this study, we refined this even further to show that the 5 min IOPTH data can identify multigland disease.
Alternatively, Gauger et al. 19 showed that the IOPTH assay was unsuccessful in detecting multiglandular disease, specifically DAs. Moreover, Haciyanli et al. 20 found that the IOPTH assay was incorrect for 57 % of the patients with DA, but that the accuracy of DA detection increased up to 80 % if the IOPTH level was used together with preoperative ultrasound and sestamibi scan. Similarly, Gill et al. 21 found that the accuracy for detecting multiglandular disease increased when the sestamibi was combined with the IOPTH level. Moreover, Weber et al. 22 and Miller et al. 23 found that the ''50 % rule'' missed a multiglandular disease in respectively 20 and 25 % of their patients.
The data presented in this report show only the usefulness of the 5 min IOPT drop to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. However, this is not intended to replace the overall accuracy of the IOPTH assay in determining operative cure. Rather, percentage decline at 5 min is useful for determining whether to wait for additional levels or to continue exploration.
Karakousis et al. 12 studied interpretation of the IOPTH levels in patients with PHPT due to multiglandular disease. They found that 29 % of the patients whose 10-to 15 min PTH levels decreased by more than 50 % after single gland excision but failed to normalize had multiglandular disease. These patients had greater serum creatinine concentrations and a lower IOPTH than the patients with SA. Thus, these authors concluded that more than a 50 % decrease in IOPTH levels for patients who undergo MIP may lead to an appreciable number of missed parathyroid adenomas or hyperplastic disease.
In this study, we examined the utility of the 5 min slope, not to determine a cure definitively, but rather to help with intraoperative decision making. We found that 85.3 % of the SA patients achieved a 35 % decline in IOPTH at 5 min compared with 24.9 % of those with multigland disease. In addition, our study showed no difference between the SA group and the DA and HA groups in terms of preoperative creatinine, but we did not calculate the glomerular filtration rate (GFR).
Whereas we found that a 5 min percentage decline of 35 % best distinguished SA from multiglandular disease, Kandil et al., specifically studied the utility of IOPTH monitoring for PHPT patients due to DA and found that the mean percentage of decrease in the 10 min IOPTH levels was 43.6 % after removal of the first gland. However, the mean percentage of decrease in the 10 min IOPTH levels was 79.7 % after removal of the second gland. These authors reported a cure rate of 98 %. Therefore, they concluded that IOPTH monitoring can accurately predict the success of parathyroidectomy for 98 % of patients with DA. 24 Although outpatient parathyroidectomy has significantly reduced the cost of parathyroidectomy, the cost reduction is due mainly to lowering of the turnover times, which reduces operating room staffing and increases operating room use for hospitals. [25] [26] [27] In fact, it has been estimated that the cost of a single operation for a patient or health insurance provider is approximately $20 per minute.
28,29 If the 5 min PTH level does not drop, the surgeon should wait for the 10 min level and if it also is still high, a bilateral exploration is indicated, which will require another 30-60 min. Waiting for IOPTH may increase the operative time. Therefore, use of the 5 min IOPTH data can potentially reduce operative times and save health care dollars and may save the surgeon a waiting time of 5-10 min, which is the time the surgeon must wait to get the extra IOPTH level.
However, despite our findings, our data should be interpreted cautiously because our study had limitations. It was a retrospective study, with the data originating from a single, high-volume university hospital, which could limit the generalizability of the findings. Importantly, the differences in GFR that might account for PTH clearance was not considered in this study. Moreover, the half-life of PTH is reported to vary substantially. 30 In addition, if the surgeon uses the 35 % cutoff, then 25 % of multigland disease will be missed, so the surgeon's judgment still plays an important role. The 5 min decline becomes another adjunct the surgeon can use in the complex decision whether to pursue a bilateral exploration. Therefore, future studies of specific patient subsets can further elucidate the utility of the 5 min levels.
CONCLUSION
The study data suggest that the use of early IOPTH levels can predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. When the IOPTH level does not drop by 35 % at 5 min after excision, the surgeon should consider further exploration rather than wait for additional levels. This simple intraoperative tool may be used to guide the decision whether to wait for IOPTH results or to proceed with further neck exploration.
